FDA and FTC Issue Joint Warning Letter to Company Selling Unproven CBD Products

FDA and FTC Issue Joint Warning Letter to Company Selling Unproven CBD Products
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have issued a joint warning letter to Rooted Apothecary LLC, of Naples, Florida for illegally selling and advertising unapproved cannabidiol (CBD) products online with unsubstantiated health claims. The warning letter states that Rooted Apothecary falsely marketed their CBD products on their social media website and online store claiming ... read more
Source: Neurology AdvisorPublished on 2019-10-24By Utsav Aiya, MD